Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) was $12.57 for the day, up 21.10% from the previous closing price of $10.38. In other words, the price has increased by $21.10 from its previous closing price. On the day, 9.12 million shares were traded. SNDX stock price reached its highest trading level at $12.98 during the session, while it also had its lowest trading level at $11.9104.
Ratios:
Our analysis of SNDX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.55 and its Current Ratio is at 4.71. In the meantime, Its Debt-to-Equity ratio is 2.19 whereas as Long-Term Debt/Eq ratio is at 2.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on August 05, 2025, Reiterated its Buy rating but revised its target price to $56 from $43 previously.
On July 10, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $18.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $37.UBS initiated its Buy rating on October 24, 2024, with a $37 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 16 ’25 when Goldan Keith A. sold 1,296 shares for $9.29 per share. The transaction valued at 12,033 led to the insider holds 92,450 shares of the business.
Metzger Michael A sold 7,534 shares of SNDX for $69,953 on Jul 16 ’25. The Chief Executive Officer now owns 298,661 shares after completing the transaction at $9.29 per share. On Jul 16 ’25, another insider, Goldan Keith A., who serves as the Officer of the company, bought 1,296 shares for $9.29 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1082803712 and an Enterprise Value of 959620224. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.83 while its Price-to-Book (P/B) ratio in mrq is 6.87. Its current Enterprise Value per Revenue stands at 12.313 whereas that against EBITDA is -2.83.
Stock Price History:
The Beta on a monthly basis for SNDX is 0.68, which has changed by -0.35604507 over the last 52 weeks, in comparison to a change of 0.21149921 over the same period for the S&P500. Over the past 52 weeks, SNDX has reached a high of $22.50, while it has fallen to a 52-week low of $8.58. The 50-Day Moving Average of the stock is 26.26%, while the 200-Day Moving Average is calculated to be -5.43%.
Shares Statistics:
SNDX traded an average of 2.26M shares per day over the past three months and 2708150 shares per day over the past ten days. A total of 86.06M shares are outstanding, with a floating share count of 82.48M. Insiders hold about 4.15% of the company’s shares, while institutions hold 116.08% stake in the company. Shares short for SNDX as of 1752537600 were 23691424 with a Short Ratio of 10.49, compared to 1749772800 on 22003021. Therefore, it implies a Short% of Shares Outstanding of 23691424 and a Short% of Float of 31.1.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
